The clinical diagnosis of infection with the most common precore mutan
t of hepatitis B virus (HBV), that with a point mutation from guanine
to adenine at nucleotide 83 in the precore region, is important becaus
e the disease may progress rapidly despite interferon therapy. A pract
ical method to detect this mutant is needed. With the ligase chain rea
ction (LCR), target DNA sequences can be amplified and single base mut
ations can be detected, We tried to detect mutant HBV by the LCR alone
, but the limit of detection (10(9) copies per tube) was too high. To
increase the sensitivity, we used the LCR on DNA already amplified by
the polymerase chain reaction (PCR), and tested serum samples from 23
subjects with chronic HBV infection for mutant and wild-type HBV. As f
ew as 10(2) copies per tube could be detected. The results corresponde
d with the results of nucleotide sequencing for 22 of the 23 patients.
The ratio of clones of mutant and total viruses was estimated for eac
h individual by PCR-coupled LCR. Seroconversion could be identified ea
rlier in the illness by an increase in this ratio than by the decrease
in HBeAg. We also tested serum samples from 11 patients with acute li
ver failure by PCR-coupled LCR. Mutant HBV was detected at a low ratio
in all 4 patients with acute self-limited hepatitis (AH). Wild-type H
BV coexisted with mutant HBV in 6 of 7 patients with fulminant hepatit
is (FH), and the mean ratio of mutant to total HBV was significantly h
igher than that in AH. PCR-coupled LCR could be used to detect mutant
HBV and to estimate the ratio of mutant to total viruses.